Posted on 22 September 2014
The article here analyses the recent manufacturing and supply partnering trends in the pharma industry. A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory. Read the full story
Posted on 07 May 2014
Supply is the provision of goods for use or sale in response to a request or demand for the goods Read the full story
Posted on 28 January 2014
Varian Medical Systems signed a biotech deal for 3 year supply agreement. Read the full story
Posted on 12 November 2013
Arena and Eisai have entered into a marketing and supply agreement for $1.796 billion, if all option are exercised. Read the full story
Posted on 10 July 2013
VIVUS enters pharma deals with big pharma Menarini for license of SPEDRA in over 40 European countries plus Australia and New Zealand and supply agreement. Read the full story
Posted on 09 May 2013
Teva Pharmaceuticals and Alexza Pharmaceuticals have entered into an exclusive U.S. pharma licencing deal and supply agreement for ADASUVE. Read the full story
Posted on 20 February 2013
Manufacturing and supply agreements have long been present in the pharmaceutical industry, as companies have sought external expertise for manufacturing and supply of finished product. Read the full story
Posted on 05 September 2012
Mylan, a top big pharma announced that its India-based subsidiary Mylan Laboratories Limited has been selected as a leading supplier of antiretroviral drugs to India's National AIDS Control Organization .
Posted on 12 January 2012
Daxor announced the receipt of a signed trial agreement from the Mayo Clinic in Scottsdale, Arizona.
This agreement will provide the Mayo Clinic with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume. Read the full story
Posted on 06 December 2011
By Patricia Van Arnum.
John Kelly, Vice President of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network. Read the full story